Transvaginal mesh controversy: Careful patient selection is key

Howard Goldman, MD, discusses the possible effects of FDA reclassification of transvaginal mesh used for prolapse as well as the importance of adequate surgical training and patient selection.

Related Videos
Doctor receiving patient in office | Image Credit © Africa Studio - stock.adobe.com
Alisa J. Stephens-Shields, PhD, answers a question during a Zoom video interview
Blurred interior of hospital | Image Credit: © jakkapan - stock.adobe.com
Dr. David Sheyn in an interview with Urology Times
Avinash Maganty, MD, answers a question during a Zoom video interview
blur image background of corridor in hospital or clinic image | Image Credit:  © whyframeshot - stock.adobe.com
Rachel Pope, MD, MPH, answers a question during a Zoom interview
blur image background of corridor in hospital or clinic image | Image credit: © whyframeshot - stock.adobe.com
Dr. David Canes in an interview with Urology Times
Urinary bladder | Image credit: © magicmine - stock.adobe.com
© 2023 MJH Life Sciences

All rights reserved.